Global Non-invasive Glucose Monitoring Devices Market - 2025 -2033
Non-invasive Glucose Monitoring Devices Market: Industry Outlook
The global non-invasive glucose monitoring devices market reached US$ 29.53 Million in 2023, with a rise of US$ 31.57 Million in 2024 and is expected to reach US$ 60.71 Million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
The global non-invasive glucose monitoring devices market is experiencing rapid growth due to the increasing prevalence of diabetes, patient preference for pain-free glucose testing, and advancements in sensor and wearable technologies. As of 2024, the market is shifting from traditional invasive methods to innovative non-invasive solutions that offer real-time, continuous glucose monitoring without the need for needles or blood samples.
Technologies like optical sensing, electromagnetic detection, and transdermal analysis are gaining traction, particularly among patients seeking comfort and convenience in diabetes management. The wearable devices segment is driving market momentum due to its seamless integration with digital health platforms and rising consumer adoption of smart health trackers. North America leads the market due to robust healthcare infrastructure and high awareness, while the Asia-Pacific region is emerging as a key growth hub.
Non-invasive Glucose Monitoring Devices Market Dynamics: Drivers & Restraints
Driver: Rising global diabetes prevalence
The global diabetes prevalence is a significant driver of growth in the non-invasive glucose monitoring devices market. For instance, with over 537 million adults worldwide living with diabetes, the number is projected to reach 643 million by 2030 and 783 million by 2045. This rise is primarily due to rapid urbanization, aging populations, unhealthy diets, sedentary lifestyles, and increasing obesity rates. The demand for more accessible, convenient, and user-friendly glucose monitoring tools has intensified.
Non-invasive glucose monitoring devices offer needle-free, real-time, and continuous glucose tracking, enhancing patient compliance and quality of life. This enables patients to manage their condition proactively, reducing the burden of monitoring fatigue and poor adherence to testing schedules. As healthcare systems shift towards preventive care and digital health integration, non-invasive glucose monitors are essential tools for population-wide diabetes management strategies.
They support better glycemic control at the individual level and allow healthcare providers and policymakers to collect actionable data for disease surveillance and intervention planning. As the global diabetes burden continues to escalate, the need for scalable, non-invasive, and cost-effective monitoring solutions will play a central role in shaping the future of diabetes care.
Driver: Increasing patient preference for pain-free, needle-free technologies
The global non-invasive glucose monitoring devices market is expanding due to the growing preference for pain-free, needle-free glucose monitoring technologies. Traditional methods, such as finger-prick tests and continuous glucose monitors, are associated with discomfort, skin irritation, infection risk, and needle anxiety, leading to poor compliance among children, elderly patients, and those requiring multiple daily checks.
As awareness of diabetes self-management increases, patients are seeking less invasive, more comfortable solutions that can seamlessly fit into their daily routines without causing physical or psychological stress. Non-invasive glucose monitoring devices, such as optical sensors, electromagnetic fields, and wearable skin patches, offer real-time glucose tracking without the need to pierce the skin. These advancements reduce the burden of daily testing and encourage more frequent monitoring, improving patient engagement and long-term disease management outcomes. The rising demand for personalized, patient-centric healthcare supports this trend, with non-invasive monitors enabling data tracking through smartphones and apps, alerts, trend analysis, and remote access for caregivers and healthcare providers.
Restraint: High cost of advanced therapies
Non-invasive glucose monitoring devices face challenges in their widespread adoption due to their lower accuracy compared to traditional methods like finger-prick blood glucose tests or continuous glucose monitoring systems. These devices, relying on technologies like optical sensing, electromagnetic waves, or bio-impedance, can be influenced by external factors, leading to variability in readings. This inconsistency raises concerns about the clinical reliability of these devices.
As a result, many non-invasive devices face delayed regulatory approvals, limited reimbursement support, and skepticism from physicians and patients. The slow pace of trust and clinical acceptance restricts their integration into mainstream diabetes care pathways, and the need for real-time and highly precise data limits the usability of current non-invasive options.
Opportunity: Growth in early detection and liquid biopsy technologies
The global non-invasive glucose monitoring devices market is experiencing significant growth opportunities in emerging markets with large diabetic populations. Countries like India, China, Brazil, Indonesia, and Mexico are experiencing a rise in diabetes cases due to urbanization, unhealthy dietary habits, sedentary lifestyles, and genetic predisposition. This has led to a pressing need for scalable, affordable, and user-friendly glucose monitoring solutions.
Non-invasive devices, particularly wearable or optical-based technologies, offer an ideal alternative in these regions where access to routine blood tests remains limited. The transformation in healthcare infrastructure across emerging economies, including digital health ecosystems, public-private partnerships, and mobile health outreach programs, is opening up access to innovative diagnostic tools. Global companies are entering these markets through strategic collaborations, localized manufacturing, and distribution partnerships to reduce costs and improve accessibility.
Non-invasive Glucose Monitoring Devices Market Segment Analysis
The global non-invasive glucose monitoring devices market is segmented based on disease type, technology, application, end user, and region.
Technology:
The wearable devices segment from the product type is expected to have 51.33% of the non-invasive glucose monitoring devices market share.
The global non-invasive glucose monitoring devices market is thriving due to the growing demand for convenient, pain-free, and real-time glucose monitoring solutions. Wearable devices like smartwatches, skin patches, and sensor-based bands offer a non-intrusive alternative to traditional finger-prick tests, enhancing patient compliance and comfort. Integration with smartphones and digital health platforms allows for better data tracking, remote monitoring, and timely interventions.
For instance, in June 2025, Garmin, a tech company, filed a patent for estimating glycated haemoglobin levels, a key indicator of long-term blood glucose trends, and may soon introduce non-invasive blood sugar monitoring for its smartwatches.
Advancements in biosensor technology, AI-driven analytics, and miniaturization have led to the development of compact, accurate, and aesthetically appealing wearables. Major market players are investing heavily in R&D to improve device accuracy and functionality. Moreover, the rise of chronic diseases and the global shift towards preventive healthcare are expected to sustain momentum in this segment.
Non-invasive Glucose Monitoring Devices Market Geographical Share
The North America global non-invasive glucose monitoring devices market was valued at 13.2 Million in 2024
The North American region dominates the global non-invasive glucose monitoring devices market due to the high prevalence of diabetes and prediabetes in the US. With over 37 million Americans affected, the need for continuous monitoring tools is urgent. The region's advanced healthcare infrastructure, medical technology availability, and public health awareness contribute to the adoption of non-invasive alternatives.
Moreover, the presence of favorable reimbursement frameworks and FDA initiatives further boosts the market. Patient-centric healthcare approaches, wearable technologies, and remote patient monitoring services post-COVID-19 create a robust ecosystem for non-invasive solutions. Venture capital funding, government grants, and strategic collaborations between tech giants and med-tech firms further strengthen the market's growth trajectory.
For instance, in February 2024, Know Labs unveiled KnowU, a wearable, non-invasive continuous glucose monitor system developed over eight months. The system incorporates the company's sensor, which it plans to submit for FDA clearance, following an accelerated development process.
The Asia-Pacific global non-invasive glucose monitoring devices market was valued at 7.41 Million in 2024
The Asia-Pacific region is experiencing rapid growth in non-invasive glucose monitoring devices due to demographic and economic trends. With over 60% of the world's diabetic population in the region, countries like India and China are experiencing a rise in type 2 diabetes cases due to urbanization, sedentary lifestyles, and changing dietary habits. This has led to a need for scalable, user-friendly, and affordable glucose monitoring solutions.
Governments are promoting digital health and early disease detection, making the region ripe for advanced monitoring technologies. The expanding middle-class population, particularly in Southeast Asia and urban India, is becoming more health-conscious and willing to invest in innovative devices.
Collaborations between global med-tech firms and regional players, along with government initiatives like India's Ayushman Bharat and China's Healthy China 2030 policy, are expected to accelerate the growth of non-invasive glucose monitoring technologies in the Asia-Pacific region.
For instance, in February 2025, Shanghai's Ruijin Hospital developed a non-invasive blood glucose monitoring technology that accurately measures glucose levels through palm placement on a device, eliminating the need for traditional finger pricks and blood draws, and has the potential to revolutionize diabetes management for millions of patients worldwide.
Non-invasive Glucose Monitoring Devices Market Major Players
The major players in the Non-invasive Glucose Monitoring Devices market include Know Labs, Inc., Conga Medical Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Medtronic, Abbott Laboratories, Dexcom, Inc., Afon Technology, Ascensia Diabetes Care, and BlueSemi among others.
Non-invasive Glucose Monitoring Devices Market Key Developments
The global market for non-invasive glucose monitoring devices is poised for robust growth, projected to expand at a CAGR of 7.5% from 2025 to 2033, reaching US$ 60.71 Million by 2033. This reflects a pivotal shift in diabetes management, driven by the rising global prevalence of diabetes, the growing demand for needle-free alternatives, and innovations in wearable biosensor technologies.
As patients increasingly seek real-time, pain-free glucose monitoring integrated with digital health ecosystems, non-invasive solutions are reshaping self-care and clinical decision-making. Wearable smart patches and optical sensors are at the forefront of this evolution, supported by favorable regulatory trends and rapid adoption in both developed and emerging markets. The sector’s transformation marks a new era in preventive, personalized diabetes care.
The global non-invasive glucose monitoring devices market report delivers a detailed analysis with 70 key tables, more than 61 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.
The global non-invasive glucose monitoring devices market reached US$ 29.53 Million in 2023, with a rise of US$ 31.57 Million in 2024 and is expected to reach US$ 60.71 Million by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
The global non-invasive glucose monitoring devices market is experiencing rapid growth due to the increasing prevalence of diabetes, patient preference for pain-free glucose testing, and advancements in sensor and wearable technologies. As of 2024, the market is shifting from traditional invasive methods to innovative non-invasive solutions that offer real-time, continuous glucose monitoring without the need for needles or blood samples.
Technologies like optical sensing, electromagnetic detection, and transdermal analysis are gaining traction, particularly among patients seeking comfort and convenience in diabetes management. The wearable devices segment is driving market momentum due to its seamless integration with digital health platforms and rising consumer adoption of smart health trackers. North America leads the market due to robust healthcare infrastructure and high awareness, while the Asia-Pacific region is emerging as a key growth hub.
Non-invasive Glucose Monitoring Devices Market Dynamics: Drivers & Restraints
Driver: Rising global diabetes prevalence
The global diabetes prevalence is a significant driver of growth in the non-invasive glucose monitoring devices market. For instance, with over 537 million adults worldwide living with diabetes, the number is projected to reach 643 million by 2030 and 783 million by 2045. This rise is primarily due to rapid urbanization, aging populations, unhealthy diets, sedentary lifestyles, and increasing obesity rates. The demand for more accessible, convenient, and user-friendly glucose monitoring tools has intensified.
Non-invasive glucose monitoring devices offer needle-free, real-time, and continuous glucose tracking, enhancing patient compliance and quality of life. This enables patients to manage their condition proactively, reducing the burden of monitoring fatigue and poor adherence to testing schedules. As healthcare systems shift towards preventive care and digital health integration, non-invasive glucose monitors are essential tools for population-wide diabetes management strategies.
They support better glycemic control at the individual level and allow healthcare providers and policymakers to collect actionable data for disease surveillance and intervention planning. As the global diabetes burden continues to escalate, the need for scalable, non-invasive, and cost-effective monitoring solutions will play a central role in shaping the future of diabetes care.
Driver: Increasing patient preference for pain-free, needle-free technologies
The global non-invasive glucose monitoring devices market is expanding due to the growing preference for pain-free, needle-free glucose monitoring technologies. Traditional methods, such as finger-prick tests and continuous glucose monitors, are associated with discomfort, skin irritation, infection risk, and needle anxiety, leading to poor compliance among children, elderly patients, and those requiring multiple daily checks.
As awareness of diabetes self-management increases, patients are seeking less invasive, more comfortable solutions that can seamlessly fit into their daily routines without causing physical or psychological stress. Non-invasive glucose monitoring devices, such as optical sensors, electromagnetic fields, and wearable skin patches, offer real-time glucose tracking without the need to pierce the skin. These advancements reduce the burden of daily testing and encourage more frequent monitoring, improving patient engagement and long-term disease management outcomes. The rising demand for personalized, patient-centric healthcare supports this trend, with non-invasive monitors enabling data tracking through smartphones and apps, alerts, trend analysis, and remote access for caregivers and healthcare providers.
Restraint: High cost of advanced therapies
Non-invasive glucose monitoring devices face challenges in their widespread adoption due to their lower accuracy compared to traditional methods like finger-prick blood glucose tests or continuous glucose monitoring systems. These devices, relying on technologies like optical sensing, electromagnetic waves, or bio-impedance, can be influenced by external factors, leading to variability in readings. This inconsistency raises concerns about the clinical reliability of these devices.
As a result, many non-invasive devices face delayed regulatory approvals, limited reimbursement support, and skepticism from physicians and patients. The slow pace of trust and clinical acceptance restricts their integration into mainstream diabetes care pathways, and the need for real-time and highly precise data limits the usability of current non-invasive options.
Opportunity: Growth in early detection and liquid biopsy technologies
The global non-invasive glucose monitoring devices market is experiencing significant growth opportunities in emerging markets with large diabetic populations. Countries like India, China, Brazil, Indonesia, and Mexico are experiencing a rise in diabetes cases due to urbanization, unhealthy dietary habits, sedentary lifestyles, and genetic predisposition. This has led to a pressing need for scalable, affordable, and user-friendly glucose monitoring solutions.
Non-invasive devices, particularly wearable or optical-based technologies, offer an ideal alternative in these regions where access to routine blood tests remains limited. The transformation in healthcare infrastructure across emerging economies, including digital health ecosystems, public-private partnerships, and mobile health outreach programs, is opening up access to innovative diagnostic tools. Global companies are entering these markets through strategic collaborations, localized manufacturing, and distribution partnerships to reduce costs and improve accessibility.
Non-invasive Glucose Monitoring Devices Market Segment Analysis
The global non-invasive glucose monitoring devices market is segmented based on disease type, technology, application, end user, and region.
Technology:
The wearable devices segment from the product type is expected to have 51.33% of the non-invasive glucose monitoring devices market share.
The global non-invasive glucose monitoring devices market is thriving due to the growing demand for convenient, pain-free, and real-time glucose monitoring solutions. Wearable devices like smartwatches, skin patches, and sensor-based bands offer a non-intrusive alternative to traditional finger-prick tests, enhancing patient compliance and comfort. Integration with smartphones and digital health platforms allows for better data tracking, remote monitoring, and timely interventions.
For instance, in June 2025, Garmin, a tech company, filed a patent for estimating glycated haemoglobin levels, a key indicator of long-term blood glucose trends, and may soon introduce non-invasive blood sugar monitoring for its smartwatches.
Advancements in biosensor technology, AI-driven analytics, and miniaturization have led to the development of compact, accurate, and aesthetically appealing wearables. Major market players are investing heavily in R&D to improve device accuracy and functionality. Moreover, the rise of chronic diseases and the global shift towards preventive healthcare are expected to sustain momentum in this segment.
Non-invasive Glucose Monitoring Devices Market Geographical Share
The North America global non-invasive glucose monitoring devices market was valued at 13.2 Million in 2024
The North American region dominates the global non-invasive glucose monitoring devices market due to the high prevalence of diabetes and prediabetes in the US. With over 37 million Americans affected, the need for continuous monitoring tools is urgent. The region's advanced healthcare infrastructure, medical technology availability, and public health awareness contribute to the adoption of non-invasive alternatives.
Moreover, the presence of favorable reimbursement frameworks and FDA initiatives further boosts the market. Patient-centric healthcare approaches, wearable technologies, and remote patient monitoring services post-COVID-19 create a robust ecosystem for non-invasive solutions. Venture capital funding, government grants, and strategic collaborations between tech giants and med-tech firms further strengthen the market's growth trajectory.
For instance, in February 2024, Know Labs unveiled KnowU, a wearable, non-invasive continuous glucose monitor system developed over eight months. The system incorporates the company's sensor, which it plans to submit for FDA clearance, following an accelerated development process.
The Asia-Pacific global non-invasive glucose monitoring devices market was valued at 7.41 Million in 2024
The Asia-Pacific region is experiencing rapid growth in non-invasive glucose monitoring devices due to demographic and economic trends. With over 60% of the world's diabetic population in the region, countries like India and China are experiencing a rise in type 2 diabetes cases due to urbanization, sedentary lifestyles, and changing dietary habits. This has led to a need for scalable, user-friendly, and affordable glucose monitoring solutions.
Governments are promoting digital health and early disease detection, making the region ripe for advanced monitoring technologies. The expanding middle-class population, particularly in Southeast Asia and urban India, is becoming more health-conscious and willing to invest in innovative devices.
Collaborations between global med-tech firms and regional players, along with government initiatives like India's Ayushman Bharat and China's Healthy China 2030 policy, are expected to accelerate the growth of non-invasive glucose monitoring technologies in the Asia-Pacific region.
For instance, in February 2025, Shanghai's Ruijin Hospital developed a non-invasive blood glucose monitoring technology that accurately measures glucose levels through palm placement on a device, eliminating the need for traditional finger pricks and blood draws, and has the potential to revolutionize diabetes management for millions of patients worldwide.
Non-invasive Glucose Monitoring Devices Market Major Players
The major players in the Non-invasive Glucose Monitoring Devices market include Know Labs, Inc., Conga Medical Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Medtronic, Abbott Laboratories, Dexcom, Inc., Afon Technology, Ascensia Diabetes Care, and BlueSemi among others.
Non-invasive Glucose Monitoring Devices Market Key Developments
- In May 2025, Afon Technology is a leader in diabetes innovation with its Glucowear device, the world's first non-invasive glucose sensor for real-time monitoring.
- In January 2025, Researchers at BITS Pilani have developed a non-invasive device using Machine Learning to detect and manage diabetes. The device eliminates the need for painful finger-pricking and allows simultaneous monitoring of critical diabetes biomarkers like glucose, lactate, uric acid, and hydrogen peroxide using sweat or urine.
The global market for non-invasive glucose monitoring devices is poised for robust growth, projected to expand at a CAGR of 7.5% from 2025 to 2033, reaching US$ 60.71 Million by 2033. This reflects a pivotal shift in diabetes management, driven by the rising global prevalence of diabetes, the growing demand for needle-free alternatives, and innovations in wearable biosensor technologies.
As patients increasingly seek real-time, pain-free glucose monitoring integrated with digital health ecosystems, non-invasive solutions are reshaping self-care and clinical decision-making. Wearable smart patches and optical sensors are at the forefront of this evolution, supported by favorable regulatory trends and rapid adoption in both developed and emerging markets. The sector’s transformation marks a new era in preventive, personalized diabetes care.
The global non-invasive glucose monitoring devices market report delivers a detailed analysis with 70 key tables, more than 61 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet by End User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Global Diabetes Prevalence
3.1.1.2. Increasing Patient Preference for pain-free, needle-free technologies.
3.1.1.3. Advancements In Wearable and Optical Sensor Technologies.
3.1.2. Restraints
3.1.2.1. Low Accuracy Compared to Invasive Methods.
3.1.2.2. High Development and Manufacturing Costs.
3.1.2.3. Regulatory Challenges and lengthy approval timelines.
3.1.3. Opportunity
3.1.3.1. Expansion in Emerging Markets With large diabetic populations
3.1.3.2. Integration With Digital Health Platforms and Mobile Apps.
3.1.4. Impact Analysis
4. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Wearable Devices*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Non-wearable Devices
6. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY TECHNOLOGY
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Optical*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Transdermal
6.4. Enzymatic
6.5. Electromagnetic
6.6. Thermal
6.7. Ultrasound
7. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Type 1 Diabetes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Type 2 Diabetes
7.4. Gestational Diabetes
7.5. Prediabetes
8. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY END USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals & Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Home Care Settings
8.4. Diagnostic Centers
8.5. Research Institutes
9. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Know Labs, Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Conga Medical Ltd.
11.3. Nemaura Medical Inc.
11.4. DiaMonTech GmbH
11.5. Medtronic
11.6. Abbott Laboratories
11.7. Dexcom, Inc
11.8. Afon Technology
11.9. Ascensia Diabetes Care
11.10. BlueSemi (LIST NOT EXHAUSTIVE)
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet by End User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Global Diabetes Prevalence
3.1.1.2. Increasing Patient Preference for pain-free, needle-free technologies.
3.1.1.3. Advancements In Wearable and Optical Sensor Technologies.
3.1.2. Restraints
3.1.2.1. Low Accuracy Compared to Invasive Methods.
3.1.2.2. High Development and Manufacturing Costs.
3.1.2.3. Regulatory Challenges and lengthy approval timelines.
3.1.3. Opportunity
3.1.3.1. Expansion in Emerging Markets With large diabetic populations
3.1.3.2. Integration With Digital Health Platforms and Mobile Apps.
3.1.4. Impact Analysis
4. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Wearable Devices*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Non-wearable Devices
6. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY TECHNOLOGY
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
6.1.2. Market Attractiveness Index, By Technology
6.2. Optical*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Transdermal
6.4. Enzymatic
6.5. Electromagnetic
6.6. Thermal
6.7. Ultrasound
7. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Type 1 Diabetes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Type 2 Diabetes
7.4. Gestational Diabetes
7.5. Prediabetes
8. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET: BY END USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals & Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Home Care Settings
8.4. Diagnostic Centers
8.5. Research Institutes
9. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. Know Labs, Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.5. SWOT Analysis
11.2. Conga Medical Ltd.
11.3. Nemaura Medical Inc.
11.4. DiaMonTech GmbH
11.5. Medtronic
11.6. Abbott Laboratories
11.7. Dexcom, Inc
11.8. Afon Technology
11.9. Ascensia Diabetes Care
11.10. BlueSemi (LIST NOT EXHAUSTIVE)
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 2 Global Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 3 Global Non-invasive Glucose Monitoring Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 4 Global Non-invasive Glucose Monitoring Devices Market Value, By End User, 2025, 2029 & 2033 (US$ Million)
Table 5 Global Non-invasive Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 6 Global Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 7 Global Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 8 Global Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 9 Global Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 10 Global Non-invasive Glucose Monitoring Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 11 Global Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 12 Global Non-invasive Glucose Monitoring Devices Market Value, By End User, 2025, 2029 & 2033 (US$ Million)
Table 13 Global Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 14 Global Non-invasive Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 15 Global Non-invasive Glucose Monitoring Devices Market Value, By Region, 2022-2033 (US$ Million)
Table 16 North America Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 17 North America Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 18 North America Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 19 North America Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 20 North America Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 21 Europe Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 22 Europe Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 23 Europe Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 24 Europe Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 25 Europe Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 26 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 27 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 28 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 29 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 30 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 31 South America Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 32 South America Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 33 South America Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 34 South America Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 35 South America Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 36 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 37 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 38 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 39 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 40 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 41 Know Labs, Inc.: Overview
Table 42 Know Labs, Inc.: Product Portfolio
Table 43 Know Labs, Inc.: Key Developments
Table 44 Conga Medical Ltd.: Overview
Table 45 Conga Medical Ltd.: Product Portfolio
Table 46 Conga Medical Ltd.: Key Developments
Table 47 Nemaura Medical Inc.: Overview
Table 48 Nemaura Medical Inc.: Product Portfolio
Table 49 Nemaura Medical Inc.: Key Developments
Table 50 DiaMonTech GmbH: Overview
Table 51 DiaMonTech GmbH: Product Portfolio
Table 52 DiaMonTech GmbH: Key Developments
Table 53 Medtronic: Overview
Table 54 Medtronic: Product Portfolio
Table 55 Medtronic: Key Developments
Table 56 Abbott Laboratories: Overview
Table 57 Abbott Laboratories: Product Portfolio
Table 58 Abbott Laboratories: Key Developments
Table 59 Dexcom, Inc.: Overview
Table 60 Dexcom, Inc.: Product Portfolio
Table 61 Dexcom, Inc.: Key Developments
Table 62 Afon Technology: Overview
Table 63 Afon Technology: Product Portfolio
Table 64 Afon Technology: Key Developments
Table 65 Ascensia Diabetes Care: Overview
Table 66 Ascensia Diabetes Care: Product Portfolio
Table 67 Ascensia Diabetes Care: Key Developments
Table 68 BlueSemi: Overview
Table 69 BlueSemi: Product Portfolio
Table 70 BlueSemi: Key Developments
Table 1 Global Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 2 Global Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 3 Global Non-invasive Glucose Monitoring Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 4 Global Non-invasive Glucose Monitoring Devices Market Value, By End User, 2025, 2029 & 2033 (US$ Million)
Table 5 Global Non-invasive Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 6 Global Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)
Table 7 Global Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 8 Global Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)
Table 9 Global Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 10 Global Non-invasive Glucose Monitoring Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Million)
Table 11 Global Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 12 Global Non-invasive Glucose Monitoring Devices Market Value, By End User, 2025, 2029 & 2033 (US$ Million)
Table 13 Global Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 14 Global Non-invasive Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Million)
Table 15 Global Non-invasive Glucose Monitoring Devices Market Value, By Region, 2022-2033 (US$ Million)
Table 16 North America Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 17 North America Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 18 North America Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 19 North America Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 20 North America Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 21 Europe Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 22 Europe Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 23 Europe Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 24 Europe Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 25 Europe Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 26 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 27 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 28 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 29 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 30 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 31 South America Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 32 South America Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 33 South America Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 34 South America Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 35 South America Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 36 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Product Type, 2022-2033 (US$ Million)
Table 37 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Technology, 2022-2033 (US$ Million)
Table 38 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Application, 2022-2033 (US$ Million)
Table 39 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By End User, 2022-2033 (US$ Million)
Table 40 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Million)
Table 41 Know Labs, Inc.: Overview
Table 42 Know Labs, Inc.: Product Portfolio
Table 43 Know Labs, Inc.: Key Developments
Table 44 Conga Medical Ltd.: Overview
Table 45 Conga Medical Ltd.: Product Portfolio
Table 46 Conga Medical Ltd.: Key Developments
Table 47 Nemaura Medical Inc.: Overview
Table 48 Nemaura Medical Inc.: Product Portfolio
Table 49 Nemaura Medical Inc.: Key Developments
Table 50 DiaMonTech GmbH: Overview
Table 51 DiaMonTech GmbH: Product Portfolio
Table 52 DiaMonTech GmbH: Key Developments
Table 53 Medtronic: Overview
Table 54 Medtronic: Product Portfolio
Table 55 Medtronic: Key Developments
Table 56 Abbott Laboratories: Overview
Table 57 Abbott Laboratories: Product Portfolio
Table 58 Abbott Laboratories: Key Developments
Table 59 Dexcom, Inc.: Overview
Table 60 Dexcom, Inc.: Product Portfolio
Table 61 Dexcom, Inc.: Key Developments
Table 62 Afon Technology: Overview
Table 63 Afon Technology: Product Portfolio
Table 64 Afon Technology: Key Developments
Table 65 Ascensia Diabetes Care: Overview
Table 66 Ascensia Diabetes Care: Product Portfolio
Table 67 Ascensia Diabetes Care: Key Developments
Table 68 BlueSemi: Overview
Table 69 BlueSemi: Product Portfolio
Table 70 BlueSemi: Key Developments
LIST OF FIGURES
Figure 1 Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 2 Global Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 4 Global Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Non-invasive Glucose Monitoring Devices Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Wearable Devices Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 9 Non-wearable Devices Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 10 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 11 Optical Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 12 Transdermal Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 13 Enzymatic Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 14 Electromagnetic Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 15 Thermal Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 16 Ultrasound Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 17 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 18 Type 1 Diabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 19 Type 2 Diabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 20 Gestational Diabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 21 Prediabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 22 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 23 Hospitals & Clinics End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 24 Home Care Settings End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 25 Diagnostic Centers End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 26 Research Institutes End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 27 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 28 North America Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 29 North America Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 30 North America Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 31 North America Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 32 North America Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 33 North America Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 34 Europe Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 35 Europe Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 36 Europe Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 37 Europe Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 38 Europe Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 39 Europe Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 40 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 41 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 42 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 43 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 44 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 45 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 46 South America Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 47 South America Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 48 South America Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 49 South America Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 50 South America Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 51 South America Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 52 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 53 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 54 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 55 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 56 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 57 Know Labs, Inc.: Financials
Figure 58 Conga Medical Ltd.: Financials
Figure 59 Nemaura Medical Inc.: Financials
Figure 60 DiaMonTech GmbH: Financials
Figure 61 Medtronic: Financials
Figure 62 Abbott Laboratories: Financials
Figure 63 Dexcom, Inc: Financials
Figure 64 Afon Technology: Financials
Figure 65 Ascensia Diabetes Care: Financials
Figure 66 BlueSemi: Financials
Figure 1 Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 2 Global Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 4 Global Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 6 Global Non-invasive Glucose Monitoring Devices Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Wearable Devices Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 9 Non-wearable Devices Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 10 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Technology, 2023-2033 (%)
Figure 11 Optical Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 12 Transdermal Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 13 Enzymatic Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 14 Electromagnetic Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 15 Thermal Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 16 Ultrasound Technology in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 17 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 18 Type 1 Diabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 19 Type 2 Diabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 20 Gestational Diabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 21 Prediabetes Application in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 22 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By End User, 2023-2033 (%)
Figure 23 Hospitals & Clinics End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 24 Home Care Settings End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 25 Diagnostic Centers End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 26 Research Institutes End User in Global Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 27 Global Non-invasive Glucose Monitoring Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 28 North America Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 29 North America Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 30 North America Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 31 North America Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 32 North America Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 33 North America Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 34 Europe Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 35 Europe Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 36 Europe Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 37 Europe Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 38 Europe Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 39 Europe Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 40 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 41 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 42 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 43 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 44 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 45 Asia-Pacific Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 46 South America Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 47 South America Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 48 South America Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 49 South America Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 50 South America Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 51 South America Non-invasive Glucose Monitoring Devices Market Share, By Country, 2024 & 2033 (%)
Figure 52 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Value, 2022-2033 (US$ Million)
Figure 53 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 54 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By Technology, 2024 & 2033 (%)
Figure 55 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By Application, 2024 & 2033 (%)
Figure 56 Middle East and Africa Non-invasive Glucose Monitoring Devices Market Share, By End User, 2024 & 2033 (%)
Figure 57 Know Labs, Inc.: Financials
Figure 58 Conga Medical Ltd.: Financials
Figure 59 Nemaura Medical Inc.: Financials
Figure 60 DiaMonTech GmbH: Financials
Figure 61 Medtronic: Financials
Figure 62 Abbott Laboratories: Financials
Figure 63 Dexcom, Inc: Financials
Figure 64 Afon Technology: Financials
Figure 65 Ascensia Diabetes Care: Financials
Figure 66 BlueSemi: Financials
